Differentiation of Dopaminergic Neurons from Mesenchymal-Like Stem Cells Derived from Human Umbilical Cord Vein
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
One of the most extensively studied populations of multipotent adult stem cells are mesenchymal stem cells (MSCs). MSCs derived from the human umbilical cord vein (HUC-MSCs) are morphologically and immunophenotypically similar to MSCs isolated from bone marrow. HUC-MSCs are multipotent stem cells, differ from hematopoietic stem cells and can be differentiated into neural cells. Since neural tissue has limited intrinsic capacity of repair after injury, the identification of alternate sources of neural stem cells has broad clinical potential. We isolated mesenchymal-like stem cells from the human umbilical cord vein, and studied transdifferentiation-promoting conditions in neural cells. Dopaminergic neuronal differentiation of HUC-MSCs was also studied. Neural differentiation was induced by adding bFGF, EGF, dimethyl sulfoxide (DMSO) and butylated hydroxyanisole (BHA) in N2 Medium and N2 supplement. The immunoreactive cells for β-tubulin III, a neuron-specific marker, GFAP, an astrocyte marker, or Gal-C, an oligodendrocyte marker, were found. HUC-MSCs treated with bFGF, SHH and FGF8 were differentiated into dopaminergic neurons that were immunopositive for tyrosine hydroxylase (TH) antibody. HUC-MSCs treated with DMSO and BHA rapidly showed the morphology of multipolar neurons. Both immunocytochemistry and RT-PCR analysis indicated that the expression of a number of neural markers including neuroD1, β-tubulin III, GFAP and nestin was markedly elevated during this acute differentiation. While the stem cell markers such as SCF, C-kit, and Stat-3 were not expressed after neural differentiation, we confirmed the differentiation of dopaminergic neurons by TH/β-tubulin III positive cells. In conclusion, HUC-MSCs can be differentiated into dopaminergic neurons and these findings suggest that HUC-MSCs are alternative cell source of therapeutic treatment for neurodegenerative diseases.
Abstract
One of the most extensively studied populations of multipotent adult stem cells are mesenchymal stem cells (MSCs). MSCs derived from the human umbilical cord vein (HUC-MSCs) are morphologically and immunophenotypically similar to MSCs isolated from bone marrow. HUC-MSCs are multipotent stem cells, differ from hematopoietic stem cells and can be differentiated into neural cells. Since neural tissue has limited intrinsic capacity of repair after injury, the identification of alternate sources of neural stem cells has broad clinical potential. We isolated mesenchymal-like stem cells from the human umbilical cord vein, and studied transdifferentiation-promoting conditions in neural cells. Dopaminergic neuronal differentiation of HUC-MSCs was also studied. Neural differentiation was induced by adding bFGF, EGF, dimethyl sulfoxide (DMSO) and butylated hydroxyanisole (BHA) in N2 Medium and N2 supplement. The immunoreactive cells for β-tubulin III, a neuron-specific marker, GFAP, an astrocyte marker, or Gal-C, an oligodendrocyte marker, were found. HUC-MSCs treated with bFGF, SHH and FGF8 were differentiated into dopaminergic neurons that were immunopositive for tyrosine hydroxylase (TH) antibody. HUC-MSCs treated with DMSO and BHA rapidly showed the morphology of multipolar neurons. Both immunocytochemistry and RT-PCR analysis indicated that the expression of a number of neural markers including neuroD1, β-tubulin III, GFAP and nestin was markedly elevated during this acute differentiation. While the stem cell markers such as SCF, C-kit, and Stat-3 were not expressed after neural differentiation, we confirmed the differentiation of dopaminergic neurons by TH/β-tubulin III positive cells. In conclusion, HUC-MSCs can be differentiated into dopaminergic neurons and these findings suggest that HUC-MSCs are alternative cell source of therapeutic treatment for neurodegenerative diseases.
참고문헌 (27)
- jorklund A, "Cell replacement therapies for central nervous system disorders", Nat Neurosci, 3, pp.537~544 (2000)
- Deans RJ, "Mesenchymal stem cells: biology and potential clinical use", Exp Hematol, 28, pp.875~884 (2000)
- Deng W, "In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP", Biochem Biophys Res Commun, 282, pp.148~152 (2001)
- Fu YS, "Conversion of human umbilical cord mesenchymal stem cells in Wharton’s jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism", Stem Cells, 24, pp.115~124 (2006)
- Gajovic S, "Retinoic acid mediates Pax6 expression during in vitro differentiation of embryonic stem cells", Differentiation, 62, pp.187~192 (1997)
- Hirsch EC, "Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease", Nature, 334, pp.345~348 (1988)
- Kageyama R, "bHLH transcription factors and mammalian neuronal differentiation", Int J Biochem Cell Biol, 29, pp.1389~1399 (1997)
- Kan I, "Dopaminergic differentiation of human mesenchymal stem cells-utilization of bioassay for tyrosine hydroxylase expression", Neurosci Lett, 419, pp.28~33 (2007)
- Kestendjieva S, "Characterization of mesenchymal stem cells isolated from the human umbilical cord", Cell Biol Int, 32, pp.724~32 (2008)
- Kim BJ, "Differentiation of adult bone marrow stem cells into neuroprogenitor cells in vitro", Neuroreport, 13, pp.1185~1188 (2002)
- Kopen GC, "Marrow stromal cells migrate throughout forebrain and cerebellum and they differentiate into astrocytes after injection into neonatal mouse brains", Proc Natl Acad Sci USA, 96, pp.10711~10716 (1999)
- Lee JE, "Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein", Science, 268, pp.836~844 (1995)
- Lee SH, "Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells", Nat Biotechnol, 18, pp.675~679 (2000)
- Lindvall O, "Transplantation into the human brain: present status and future possibilities", Neurol neurosurg Psychiatry suppl, pp.39~54 (1989)
- Mahowald MB, "Transplantation of neural tissue from fetuses", Science, 235, pp.1307~1308 (1987)
- Maxwell SL, "Midbrain dopaminergic development in vivo and in vitro from embryonic stem cells", Anat, 207, pp.209~218 (2005)
- McCormick MB, "NeuroD2 and Neuro D3: distinct expression patterns and transcriptional activation potentials within the neuroD gene family", Mol Cell Biol, 16, pp.5792~5800 (1996)
- Patapoutian A, "Roles of Wnt proteins in nenural development and maintenance", Curr Opin Neurobiol, 10, pp.392~399 (2000)
- Paul G, "Stem cells: hype or hope?", Drug Discov Today, 7, pp.295~302 (2002)
- Perrier AL, "Derivation of midbrain dopamine neurons from human embryonic stem cells", Proc Natl Acad Sci USA, 101, pp.12543~12548 (2004)
- Pittenger MF, "Multilineage potential of adult human mesenchymal stem cells", Science, 284, pp.143~147 (1999)
- Sanchez-Ramos J, "Adult bone marrow stromal cells differentiate into neural cells in vitro", Exp Neurol, 164, pp.247~256 (2000)
- Schwartz RE, "Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells", J Clin Invest, 109, pp.1291~1302 (2002)
- Smidt MP, "A second independent pathway for development of mesencephalic dopaminergic neurons requires Lmx1b", Nat Neurosci, 3, pp.337~341 (2000)
- Toma C, "Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart", Circulation, 105, pp.93~98 (2002)
- Woodbury D, "Adult rat and human bone marrow stromal cells differentiate into neurons", J Neurosci Res, 61, pp.364~370 (2000)
- Ye W, "FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate", Cell, 93, pp.755~766 (1998)